AI assistant
REPLIGEN CORP — Director's Dealing 2024
Mar 19, 2024
30826_dirs_2024-03-19_616284bc-c11f-4291-ade5-fb2a15755934.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2024-03-18
Reporting Person: Pax Margaret (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-03-18 | Common Stock | A | 92 | $0.00 | Acquired | 92 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-18 | Stock Option (Right to Buy) | $194.25 | A | 195 | Acquired | 2034-03-18 | Common Stock (195) | Direct |
| 2024-03-18 | Stock Option (Right to Buy) | $194.25 | A | 2236 | Acquired | 2034-03-18 | Common Stock (2236) | Direct |
Footnotes
F1: Ms. Pax was awarded 92 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 16, 2024, the date of the annual meeting of the Company's shareholders. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
F2: Award vests in full on May 16, 2024, the date of the annual meeting of the Company's shareholders.
F3: The shares vest in equal annual instalments over a three-year period with each such vesting date occurring on the earlier of the anniversary of the grant date or the date of the annual meeting of the Company's shareholders of the applicable year of such three-year period.